644 related articles for article (PubMed ID: 8549871)
41. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
42. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
Wheeler MB; Lu M; Dillon JS; Leng XH; Chen C; Boyd AE
Endocrinology; 1993 Jul; 133(1):57-62. PubMed ID: 8391428
[TBL] [Abstract][Full Text] [Related]
43. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
[TBL] [Abstract][Full Text] [Related]
44. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
[TBL] [Abstract][Full Text] [Related]
45. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes.
Montrose-Rafizadeh C; Yang H; Wang Y; Roth J; Montrose MH; Adams LG
J Cell Physiol; 1997 Sep; 172(3):275-83. PubMed ID: 9284947
[TBL] [Abstract][Full Text] [Related]
46. Heterologous desensitization of insulin secretion by GIP (glucose-dependent insulinotropic peptide) in INS-1 cells: the significance of Galphai2 and investigations on the mechanism involved.
Rucha A; Verspohl EJ
Cell Biochem Funct; 2005; 23(3):205-12. PubMed ID: 15376236
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory effect of enterostatin on the beta cell response to digestive insulinotropic peptides.
Rodríguez-Gallardo J; Silvestre RA; Marco J
Int J Obes Relat Metab Disord; 1999 Aug; 23(8):787-92. PubMed ID: 10490778
[TBL] [Abstract][Full Text] [Related]
48. Glucagon-like peptide-1 binding to rat skeletal muscle.
Delgado E; Luque MA; Alcántara A; Trapote MA; Clemente F; Galera C; Valverde I; Villanueva-Peñacarrillo ML
Peptides; 1995; 16(2):225-9. PubMed ID: 7784253
[TBL] [Abstract][Full Text] [Related]
49. Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy.
Moffett RC; Vasu S; Thorens B; Drucker DJ; Flatt PR
PLoS One; 2014; 9(6):e96863. PubMed ID: 24927416
[TBL] [Abstract][Full Text] [Related]
50. Selectivity of peptide ligands for the human incretin receptors expressed in HEK-293 cells.
Al-Sabah S; Al-Fulaij M; Ahmed HA
Eur J Pharmacol; 2014 Oct; 741():311-5. PubMed ID: 25179575
[TBL] [Abstract][Full Text] [Related]
51. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
Kolligs F; Fehmann HC; Göke R; Göke B
Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
[TBL] [Abstract][Full Text] [Related]
52. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
[TBL] [Abstract][Full Text] [Related]
53. Glucagon-like peptide-1 is a physiological incretin in rat.
Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
[TBL] [Abstract][Full Text] [Related]
54. Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
Moffett RC; Vasu S; Flatt PR
Biochim Biophys Acta; 2015 Jun; 1850(6):1206-14. PubMed ID: 25688757
[TBL] [Abstract][Full Text] [Related]
55. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
[TBL] [Abstract][Full Text] [Related]
56. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
Ding WG; Gromada J
Diabetes; 1997 Apr; 46(4):615-21. PubMed ID: 9075801
[TBL] [Abstract][Full Text] [Related]
57. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
Yada T; Itoh K; Nakata M
Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
[TBL] [Abstract][Full Text] [Related]
58. Interaction of glucagon-like peptide-I (7-37) and somatostatin-14 on signal transduction and proinsulin gene expression in beta TC-1 cells.
Fehmann HC; Strowski M; Göke B
Metabolism; 1994 Jun; 43(6):787-92. PubMed ID: 7911222
[TBL] [Abstract][Full Text] [Related]
59. GIP(3-30)NH
Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
Siegel EG; Schulze A; Schmidt WE; Creutzfeldt W
Eur J Clin Invest; 1992 Mar; 22(3):154-7. PubMed ID: 1582439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]